LINCOLN- bacitracin zinc neomycin sulfate polymyxin b sulfate ointment 
Lincoln Pharmaceutical Ltd.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Drug Facts

Bacitracin Zinc 400 units- Neomycin Sulfate 5 mg (Equivalent to 3.5 mg Neomycin) Polymyxin B sulfate 5000 units

Drug Facts

First Aid antibiotic

Drug Facts

Uses

Drug Facts

For External use only

Drug Facts

Drug Facts

Drug Facts

Drug Facts

If swallowed, get medical help or contact a Poison Control Center right away.

Drug Facts

Drug Facts

white petrolatum

principal display

LINCOLN 
bacitracin zinc neomycin sulfate polymyxin b sulfate ointment
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:69636-3025
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
POLYMYXIN B SULFATE (UNII: 19371312D4) (POLYMYXIN B - UNII:J2VZ07J96K) POLYMYXIN B5000 [USP'U]  in 1 g
NEOMYCIN SULFATE (UNII: 057Y626693) (NEOMYCIN - UNII:I16QD7X297) NEOMYCIN3.5 mg  in 1 g
BACITRACIN ZINC (UNII: 89Y4M234ES) (BACITRACIN - UNII:58H6RWO52I) BACITRACIN400 [USP'U]  in 1 g
Inactive Ingredients
Ingredient NameStrength
PETROLATUM (UNII: 4T6H12BN9U)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:69636-3025-20.5 g in 1 PACKET; Type 0: Not a Combination Product05/17/2013
2NDC:69636-3025-30.9 g in 1 PACKET; Type 0: Not a Combination Product05/17/2013
3NDC:69636-3025-528.3 g in 1 TUBE; Type 0: Not a Combination Product05/17/2013
4NDC:69636-3025-414 g in 1 TUBE; Type 0: Not a Combination Product05/17/2013
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart333B05/17/2013
Labeler - Lincoln Pharmaceutical Ltd. (915839373)

Revised: 4/2016
Document Id: 2fae7dd2-1d16-0459-e054-00144ff88e88
Set id: 2fae7dd2-1d15-0459-e054-00144ff88e88
Version: 1
Effective Time: 20160408
 
Lincoln Pharmaceutical Ltd.